Monoclonal gammopathy associated with dermatological manifestations are a well-
recognized complication. These skin disorders can be associated with infiltration and …

Immunoglobulin light chain (AL) amyloidosis is a malignant plasma cell dyscrasia causing
multi-organ morbidity. High dose melphalan and autologous stem cell transplantation …

Autologous stem cell transplantation (ASCT) is considered to be the best method to achieve
deep haematological/organ responses and improve survival in selected patients with AL …

Background Stem cell transplantation has been an established modality for the treatment of
multiple myeloma for more than 30 years. This technique is applied globally and is …

Introducción: La amiloidosis por cadenas livianas de inmunoglobulinas (AL) es una
enfermedad poco frecuente. El tratamiento implica un desafío, justificado en parte por el …

Objectives The benefit of autologous stem cell transplantation (ASCT) in the treatment of
light chain (AL) amyloidosis requires re‐evaluation in the modern era. This retrospective …

Introduction Immunoglobulin light chain (AL) amyloidosis is caused by the deposition of
monoclonal immunoglobulin light chains, for which autologous hematopoietic cell …

Monoclonal gammopathy associated with dermatological manifestations are a well-
recognized complication. These skin disorders can be associated with infiltration and …

Background: Systemic light chain (AL) amyloidosis is a rare disorder characterised by the
production of abnormal clonal light chains, which mis-fold and deposit as amyloid fibrils …

Autologous stem cell transplantation (ASCT) has been an essential part of the treatment
armamentarium in light chain (AL) amyloidosis for several decades. Patients who achieve a …